Hepatitis C, Chronic
Research News and Information

Friday, March 19, 2010

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.

13 Nov 2009 Interleukin-6 (IL-6) may play a role in the pathogenesis of hepatocellular carcinoma (HCC). Recently, it was reported in mouse models that estrogen-mediated inhibition of IL-6 production explains the gender disparity in HCC. We conducted a ... Read more...

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

13 Oct 2009 BACKGROUND: The aim of this study was to assess the efficacy and safety of pegylated interferon (IFN) plus ribavirin (RBV) in human immunodeficiency virus (HIV) and hepatitis C virus (HCV)-coinfected patients with severe immunodeficiency in a ... Read more...

Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients.

13 Oct 2009 OBJECTIVE: To provide information about the incidence and predictors of liver decompensation and death due to liver failure in human immunodeficiency virus (HIV)-infected patients with compensated hepatitis C virus (HCV)-related cirrhosis. METHODS: ... Read more...

Latest indexed articles for 'Hepatitis C, Chronic'

These are the very latest articles for this heading:

• Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences. 13 Nov 2009
• Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. 27 Oct 2009
• Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression. 13 Oct 2009
• Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients. 13 Oct 2009
• Swine H1N1 influenza in a post liver transplant patient. 7 Oct 2009
• A lymphotoxin-driven pathway to hepatocellular carcinoma. 4 Oct 2009
• Lymphotoxins: new targets for hepatocellular carcinoma. 4 Oct 2009
• A 45-year-old man with a history of hepatitis C and testicular cancer presents with cavitary lung lesions and palpable purpura. 29 Sep 2009
• Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients. 29 Sep 2009
• Hyaline inclusion myopathy: unmasked by statin therapy. 29 Sep 2009
• Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. 29 Sep 2009
• A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. 29 Sep 2009
• Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial. 29 Sep 2009
• Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. 29 Sep 2009
• B-mode ultrasound with algorithm based on statistical analysis of signals: evaluation of liver fibrosis in patients with chronic hepatitis C. 29 Sep 2009
• Appropriate requesting of serum tumour markers. 20 Sep 2009
• Genomics: Hepatitis C virus gets personal. 15 Sep 2009
• Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. 12 Sep 2009
• IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. 11 Sep 2009
• Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. 11 Sep 2009

See a longer list of these articles.

Technical information about 'Hepatitis C, Chronic'

Definition: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Descriptor UI: D019698

Alternative terms: Hepatitis C, Chronic; Chronic Hepatitis C;

Allowable Qualifiers: blood; cerebrospinal fluid; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; transmission; urine; veterinary; ultrasonography; virology;

Tree Number: C02.440.440.120; C02.782.350.350.120; C06.552.380.350.120; C06.552.380.705.440.120;

History Note: 98